Option Care Health (NASDAQ:OPCH – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday, Zacks.com reports.
According to Zacks, “Option Care Health Inc provides infusion and home care management solutions. The Company offers products, services and condition-specific clinical management programs for gastrointestinal abnormalities, infectious diseases, cancer, organ and blood cell transplants, bleeding disorders and heart failures. Option Care Health Inc., formerly known as BioScrip Inc., is based in Denver, United States. “
Shares of Option Care Health stock opened at $29.45 on Friday. The firm has a fifty day simple moving average of $26.28 and a 200-day simple moving average of $25.82. The company has a current ratio of 1.55, a quick ratio of 1.15 and a debt-to-equity ratio of 0.90. Option Care Health has a 1-year low of $16.02 and a 1-year high of $30.32. The stock has a market capitalization of $5.31 billion, a price-to-earnings ratio of 38.25, a PEG ratio of 1.41 and a beta of 1.38.
In related news, COO Harriet Booker sold 6,000 shares of the business’s stock in a transaction on Monday, February 7th. The shares were sold at an average price of $23.61, for a total transaction of $141,660.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders have sold 18,000 shares of company stock worth $461,460 in the last ninety days. 47.00% of the stock is currently owned by insiders.
Institutional investors have recently made changes to their positions in the business. Compagnie Lombard Odier SCmA bought a new stake in Option Care Health in the 4th quarter valued at $31,000. Covestor Ltd bought a new stake in Option Care Health in the 4th quarter valued at $46,000. US Bancorp DE increased its holdings in Option Care Health by 16.4% in the 3rd quarter. US Bancorp DE now owns 2,843 shares of the company’s stock valued at $69,000 after buying an additional 400 shares during the period. New York State Teachers Retirement System bought a new stake in Option Care Health in the 3rd quarter valued at $197,000. Finally, Aristides Capital LLC bought a new stake in Option Care Health in the 3rd quarter valued at $201,000. 97.80% of the stock is currently owned by hedge funds and other institutional investors.
Option Care Health Company Profile (Get Rating)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
- Get a free copy of the StockNews.com research report on Option Care Health (OPCH)
- Lululemon Rises On Wave Of Price Target Increases
- Is Nvidia (NASDAQ: NVDA) About To Rip Higher?
- The Top Is In For Infosys
- 3 Stellar Steel Stocks to Buy Now
- Bed Bath & Beyond Uncovers The Problem With Q1 Earnings Season
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.